Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells
- PMID: 29335647
- DOI: 10.1038/s41590-017-0030-x
Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells
Abstract
Pulmonary immunity requires tight regulation, as interstitial inflammation can compromise gas exchange and lead to respiratory failure. Here we found a greater number of aged CD11bhiL-selectinloCXCR4+ polymorphonuclear leukocytes (PMNs) in lung vasculature than in the peripheral circulation. Using pulmonary intravital microscopy, we observed lung PMNs physically interacting with B cells via β2 integrins; this initiated neutrophil apoptosis, which led to macrophage-mediated clearance. Genetic deletion of B cells led to the accumulation of aged PMNs in the lungs without systemic inflammation, which caused pathological fibrotic interstitial lung disease that was attenuated by the adoptive transfer of B cells or depletion of PMNs. Thus, the lungs are an intermediary niche in the PMN lifecycle wherein aged PMNs are regulated by B cells, which restrains their potential to cause pulmonary pathology.
Similar articles
-
Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice.J Immunol. 2019 May 1;202(9):2760-2771. doi: 10.4049/jimmunol.1900039. Epub 2019 Mar 25. J Immunol. 2019. PMID: 30910861 Free PMC article.
-
VCAM-1-mediated neutrophil infiltration exacerbates ambient fine particle-induced lung injury.Toxicol Lett. 2019 Mar 1;302:60-74. doi: 10.1016/j.toxlet.2018.11.002. Epub 2018 Nov 15. Toxicol Lett. 2019. PMID: 30447258
-
A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent.J Immunol. 2011 Jan 15;186(2):1107-18. doi: 10.4049/jimmunol.0903476. Epub 2010 Dec 15. J Immunol. 2011. PMID: 21160052
-
Immune mechanisms in fibrotic interstitial lung disease.Cell. 2024 Jul 11;187(14):3506-3530. doi: 10.1016/j.cell.2024.05.015. Cell. 2024. PMID: 38996486 Review.
-
The role of the adenosinergic system in lung fibrosis.Pharmacol Res. 2013 Oct;76:182-9. doi: 10.1016/j.phrs.2013.08.004. Epub 2013 Aug 28. Pharmacol Res. 2013. PMID: 23994158 Review.
Cited by
-
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).Ann Rheum Dis. 2021 Feb;80(2):143-150. doi: 10.1136/annrheumdis-2020-217230. Epub 2020 Oct 9. Ann Rheum Dis. 2021. PMID: 33037004 Free PMC article. Review.
-
Competitive survival of clonal serial Pseudomonas aeruginosa isolates from cystic fibrosis airways in human neutrophils.iScience. 2023 Mar 24;26(4):106475. doi: 10.1016/j.isci.2023.106475. eCollection 2023 Apr 21. iScience. 2023. PMID: 37096049 Free PMC article.
-
From Mouse to Man and Back: Closing the Correlation Gap between Imaging and Histopathology for Lung Diseases.Diagnostics (Basel). 2020 Aug 26;10(9):636. doi: 10.3390/diagnostics10090636. Diagnostics (Basel). 2020. PMID: 32859103 Free PMC article. Review.
-
Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study.RMD Open. 2024 Mar 22;10(1):e003715. doi: 10.1136/rmdopen-2023-003715. RMD Open. 2024. PMID: 38519110 Free PMC article.
-
Tumors exploit CXCR4hiCD62Llo aged neutrophils to facilitate metastatic spread.Oncoimmunology. 2021 Jan 20;10(1):1870811. doi: 10.1080/2162402X.2020.1870811. Oncoimmunology. 2021. PMID: 33537175 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
